Trial Profile
A study of NIAGEN in patients with systolic heart failure
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 22 Feb 2018
Price :
$35
*
At a glance
- Drugs Nicotinamide riboside (Primary)
- Indications Heart failure
- Focus Adverse reactions
- 22 Feb 2018 New trial record
- 20 Feb 2018 According to a ChromaDex media release, this trial is underway at the University of Washington and is expected to complete at the end of June, 2018.